Lim MJ(1), Shahri NNM(1), Taha H(2), Mahadi AH(3), Kusrini E(4), Lim JW(5), Usman A(6). Author information:
(1)Department of Chemistry, Faculty of Science, Universiti Brunei Darussalam,
Jalan Tungku Link, Gadong BE1410, Brunei Darussalam.
(2)Environmental and Life Sciences, Faculty of Science, Universiti Brunei
Darussalam, Jalan Tungku Link, Gadong BE1410, Brunei Darussalam.
(3)Centre for Advanced Material and Energy Sciences, Universiti Brunei
Darussalam, Jalan Tungku Link, Gadong BE1410, Brunei Darussalam.
(4)Department of Chemical Engineering, Faculty of Engineering, Universitas
Indonesia, Kampus Baru UI-Depok, 16424, Indonesia.
(5)Department of Fundamental and Applied Sciences, HICoE-Centre for Biofuel and
Biochemical Research, Institute of Self-Sustainable Building, Universiti
Teknologi PETRONAS, 32610 Seri Iskandar, Perak Darul Ridzuan, Malaysia.
(6)Department of Chemistry, Faculty of Science, Universiti Brunei Darussalam,
Jalan Tungku Link, Gadong BE1410, Brunei Darussalam. Electronic address:
[Email]
Chitin-encapsulated cadmium sulfide quantum dots (CdS@CTN QDs) were successfully synthesized from chitin and Cd(NO3)2 precursor using the colloidal chemistry method, toward the development of biocompatible and biodegradable QDs for biomedical applications. CdS@CTN QDs exhibited the nanocrystalline cubic CdS encapsulated by α-chitin. The average particle size of CdS@CTN QDs was estimated using empirical Henglein model to be 3.9 nm, while their crystallite size was predicted using Scherrer equation to be 4.3 nm, slightly larger compared to 3-mercaptopropionic acid-capped CdS QDs (3.2 and 3.6 nm, respectively). The mechanism of formation was interpreted based on the spectroscopic data and X-ray crystal structures of CdS@CTN QDs fabricated at different pH values and mass ratios of chitin to Cd(NO3)2 precursor. As an important step to explore potential biomolecular and biological applications of CdS@CTN QDs, their antibacterial activities were tested against four different bacterial strains; i.e. Escherichia coli, Bacillus subtillus, Staphylococcus aureus and Pseudomonas aeruginosa.
OUR JOURNALS
Having over 250 Research scholars worldwide and more than 400 articles online with open access.
